The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NCRI 2018 | The growth of harm reduction products for smokers: benefits and considerations
Lion Shahab, MSc, PhD, CPsychol, AFBPsS, PGCLTHE, from University College London, London, UK, discusses the regulatory and safety considerations that need to be made as new harm reduction products for cigarette smokers are developed and introduced. Increasing options available may also lead to a reduction in the numbers of cigarette smokers in the long run, suggests Dr Shahab from the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.
